Form 4: Strata Skin Sciences CEO Dolev Rafaeli Acquires 19,100 Shares of Common Stock
SEC Form 4 Filing
Dolev Rafaeli, CEO of Strata Skin Sciences, Inc., purchased 19,100 shares of common stock at $3.14 per share on July 15, 2024.
Summary
- On July 15, 2024, Dolev Rafaeli, the CEO of Strata Skin Sciences, Inc. (SSKN), acquired 19,100 shares of the company's common stock.
- The purchase price was $3.14 per share.
- Following this transaction, Rafaeli directly owns 143,156 shares of Strata Skin Sciences.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. The CEO's purchase of shares suggests confidence in the company, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insiders purchasing shares in their own companies is generally seen as a positive sign. It suggests that those with the most knowledge of the company's prospects believe the stock is undervalued or that the company is likely to perform well in the future.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 07/15/2024 | Date of transaction: Dolev Rafaeli purchased 19,100 shares of SSKN common stock. |
| 07/17/2024 | Date of signature on the Form 4 filing. |
Keywords
Strata Skin Sciences, SSKN, Dolev Rafaeli, CEO, stock purchase, Form 4, beneficial ownership, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.